1. Better Prepared to Move Early Phase Trials.
¨ç Interpretation of non-clinical data for clinical development planning.
¨è How modeling helps FTIH – including CRM.
Moderator : Áöµ¿Çö(±¹°¡ÀÓ»ó½ÃÇèÁö¿øÀç´Ü)
Speaker : ¨ç ½Å¿µ±Ù(Ãæ³²´ëÇб³ ¾àÇдëÇÐ)
¨è ÀÓÇü¼®(¾Æ»êº´¿ø)
13:00
Lunch
14:00
2. Implementation of Novel Clinical Trial Designs in Cancer Trials (I). ¨ç Industry perspective. ¨è Investigators perspective. ¨é Statistical consideration
Moderator : ¹®ÇѸ²(Å¥¾î·£Äɾ¼Ä¡)
Speaker : ¹Ú°æ¹Ì(GENOME & COMPANY), ¿Àµµ¿¬(¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ)
16:00
Coffee brea
16:30
3. Implementation of Novel Clinical Trial Designs in Cancer Trials (II). (Ex)- "Expansion Cohorts", "Master Protocols", "Single-arm design", "Real-world evidence"
Moderator : ¹®ÇѸ²(Å¥¾î·£Äɾ¼Ä¡) Speaker : À̼öÇö(°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ)
18:00
Wrap up
Day2 10¿ù 16ÀÏ(¼ö)
9:30
Registration
10:00
4. Understanding FDA Expedited Approvals for Effective Regulatory Strategy.
Moderator : ÃÖ¼º±¸(KSPM) Speaker : À强ÈÆ(FDA)
11:30
5. First in Human Design. : Strategy for efficient clinical development.
Moderator : ÀåÀÎÁø(¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ) Speaker : À̽Âȯ(¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ)